Anthea Peters

17PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 05, 2026
Dual action of pimozide through lysosome disruption and inhibition of STATs induces apoptosis in chronic lymphocytic leukemia (CLL).

|Jan 21, 2026
Fibrin-Associated Large B-Cell Lymphoma of Prosthetic Aortic Valve and Aortic Root Graft.

Ashish Rajput, Abdulrahim Alabdulsalam, Claribeth Ruano

|Oct 06, 2025
Management of Canadian patients with refractory or relapsed diffuse large B-cell lymphoma in the real world: a subanalysis of the RE-MIND2 study.

Anthea Peters, Grzegorz S Nowakowski, Rosy Dabas

|Mar 21, 2025
Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review.

Adrian de Boer, Chris McCaw, Margaret Ackman

|Jun 26, 2024
Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy.

Madhumita S Manivannan, Xiaoyan Yang, Nirav Patel

|Feb 24, 2023
Management of Marginal Zone Lymphoma: A Canadian Perspective.

Anthea Peters, Mary-Margaret Keating, Anna Nikonova

Pageof 3

Frequent Collaborators

2 joint publications

Ryan J Stubbins

2 joint publications

Raymond Lai

2 joint publications

Douglas Stewart

2 joint publications

Robert Puckrin